Berkeley
Ethical Traveler Announces 2025’s ‘Ten Best Ethical Destinations’ Awards
BERKELEY, Calif. — Every year, California-based Ethical Traveler reviews the world’s developing nations for their commitment to human rights, social welfare, environmental protection, and animal welfare. The ten destinations showing the most impressive progress are honored with “Best Ethical Destinations” Awards. These worthy countries, many of which are island nations, stand to benefit greatly from our travel dollars….
Ethical Traveler Announces ‘Ten Best Ethical Destinations’ Awards for 2023
BERKELEY, Calif. — Every year, California-based Ethical Traveler reviews the world’s developing nations for their commitment to human rights, social welfare, environmental protection, and animal welfare. The ten destinations showing the most impressive progress are honored with “Best Ethical Destinations” Awards. These worthy countries, including several island nations, stand to benefit greatly from our travel dollars in a post-pandemic world….
Share International Announces Campaign to End All War
BERKELEY, Calif. — Share International USA, a non-profit educational organization, announced today the start of a daily prayer/meditation vigil designed to engage the power of the people to bring peace in the current Russia/Ukraine conflict as well as all others ongoing worldwide….
Ethical Traveler Announces 2021’s ‘Ten Best (Post-Pandemic) Destinations’ Awards
BERKELEY, Calif. — Every year, California-based Ethical Traveler reviews the world’s developing nations for their commitment to human rights, social welfare, and environmental protection. The ten destinations with the most impressive records are honored with Ethical Destinations Awards….
Flightpath Biosciences Launches via Illumina Accelerator to Conduct Largest Clinical Biomarker Study in Lyme Disease
BERKELEY, Calif. — Flightpath Biosciences, a life sciences company, launched today claiming a spot in Illumina Accelerator’s second global class to develop diagnostics and microbiome-targeted therapeutics to treat rare pathogen-driven diseases. The company has operated in stealth since its founding in mid-2019 and has built a pipeline of drug candidates for a wide range of diseases, starting with acute and Persistent Lyme Disease (PLD)….